En Carta Diagnostics secured €1.5 million in pre-seed funding led by CentraleSupélec Venture to advance platform for early Lyme disease detection
Amount Raised
€1.5 Million
Round Type
Pre-Seed
ParisBiotechnologyHealth CareHealth DiagnosticsInvestors
Description
En Carta Diagnostics, a startup specializing in rapid Point-of-Care molecular diagnostics, has announced the completion of a €1.5 million pre-seed funding round. This investment will be utilized to further the development of a prototype diagnostic kit for early Lyme disease detection and to facilitate scalability.
Quick answer
En Carta Diagnostics raised €1.5 Million in a Pre-Seed round, dated May 22, 2024. Investors: Centrale Supélec Venture and High Profile Business Angels. En Carta Diagnostics is based in Paris, Ile-de-France, France.
- How much did En Carta Diagnostics raise?
- En Carta Diagnostics raised €1.5 Million in a Pre-Seed round on May 22, 2024.
- Who invested in En Carta Diagnostics?
- Centrale Supélec Venture and High Profile Business Angels are named as investors in this round.
- What does En Carta Diagnostics do?
- Diagnostics for Better care, Everywhere.
- Where is En Carta Diagnostics based and how big is it?
- En Carta Diagnostics is based in Paris, Ile-de-France, France.
- Who are the decision-makers at En Carta Diagnostics?
- Fundz holds 1 contact at En Carta Diagnostics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Health Diagnostics and Biotechnology around the same time
Companies in the same sectors as En Carta Diagnostics that raised within 45 days of this round, from Fundz verified event records.
- Cerenome, Inc. raised $18M (Post-IPO Equity) on May 6, 2024.
- Karius® raised $100M (Series C) on May 2, 2024.
- Testmate Health raised $6M (Seed) on May 2, 2024.
- Insight Molecular Diagnostics Inc. raised $16M on April 11, 2024.
- Virpax Pharmaceuticals raised $2.5M on July 5, 2024.
- NGM Bio raised $73M on July 5, 2024.
Who to call at En Carta Diagnostics, and when
A new round usually means En Carta Diagnostics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day En Carta Diagnostics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at En Carta Diagnostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at En Carta Diagnostics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment En Carta Diagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
En Carta Diagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.